Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call
October 29, 2024 16:30 ET
|
Neuronetics
MALVERN, Pa., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
October 14, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
September 25, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
September 19, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Releases Software Upgrades to Elevate Patient Care
September 16, 2024 08:32 ET
|
Neuronetics
MALVERN, Pa., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories
September 03, 2024 08:29 ET
|
Neuronetics
MALVERN, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
August 20, 2024 08:29 ET
|
Neuronetics
MALVERN, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge
August 12, 2024 07:15 ET
|
Neuronetics
MALVERN, Pa. and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”) today announced that they have...
Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results
August 12, 2024 07:10 ET
|
Neuronetics
MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 05, 2024 16:36 ET
|
Neuronetics
MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...